HC Wainwright Issues Negative Estimate for ORKA Earnings
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) – Investment analysts at HC Wainwright dropped their Q1 2025 earnings per share estimates for shares of Oruka Therapeutics in a research report issued to clients and investors on Monday, April 28th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of […]
